one hundred fifty-five eligible women with metastatic breast cancer were randomly allocated to receive monthly cycles of either cmfp ( cyclophosphamide , methotrexate , 5-fluorouracil , prednisone ) or caf ( cyclophosphamide , doxorubicin , 5-fluorouracil ) , and 12 patients were studied to evaluate the effects of additional corynebacterium parvum immunotherapy .
C0055985
cmfp
C0032952
prednisone